CLOV Overview

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.

Wall Street analysts forecast CLOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLOV is3.35 USD with a low forecast of 3.00 USD and a high forecast of 3.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Clover Health Investments Corp revenue for the last quarter amounts to 749.19M USD, increased 62.05

Clover Health Investments Corp. EPS for the last quarter amounts to 0.05 USD, decreased

Clover Health Investments Corp (CLOV) has 724 emplpoyees as of May 10 2026.

Today CLOV has the market capitalization of 1.64B USD.